*Calculation i.e.: where part of a vial is required to make up a dose a calculation would be necessary. (when 2 x 20mg tablets are required to make 40mg dose this is not considered to be a calculation).
We asked you in January to update to v4.7.2. After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.
To update to the latest release:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Welcome to the February 2025 update from the RDS team
A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:
The release will also incorporate a number of small fixes, including:
We will let you know when the date and time for the new release are confirmed.
There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.
The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.
Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.
At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .
We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.
Some important toolkits in development by the RDS team include:
The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.
To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)
To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form - also available in End-user and Provider sections of the RDS Learning and Support area. If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.
With kind regards
Right Decision Service team
Healthcare Improvement Scotland
For the administration of Controlled Drugs (CD’s) where possible the staff undertaking the whole process from selection of the drug to administration should be 2 registered staff members.
NHS Borders Code of Practice for the Control of Medicines policy states that this may be a registered nurse, midwife, doctor or ODP. However, in a community hospital/mental health ward setting it is recognised that there are frequently occasions (i.e.: night shift) where there is only one registered nurse on duty. In these circumstances in order to ensure that patients are administered their CD’s in a timely manner then Health Care Support Workers (HCSW’s) that have completed relevant training can act as a witness for the preparation and administration of controlled drugs.
This should only be in circumstances when there is not another registered nurse available and should not become standard practice.
Two RN’s to administer CD’s is always the preferred option. When there is not another RN on duty however, using a trained HCSW is considered to be a safer option than a single nurse check.
For the administration of controlled drugs single nurse checks must not be considered. NHS Borders Code of Practice for the Control of Medicines policy does not cover single nurse checking so it would be a breach of policy if a nurse opted to administer a controlled drug without a witness.
When asking HCSW’s to act as a witness the RN must be assured that the HCSW has completed all relevant training and are competent and confident in the task. It is the responsibility of the senior charge nurse (SCN) to ensure that HCSW’s have completed relevant training.
The relevant Learn pro unit ‘Controlled drugs HCSW’s’ is available via NHS Borders intranet site. This must be completed by the HCSW before they can undertake the role as second checker.
HCSW’s role in relation to CD’s
HCSW’s that are required to act as a witness for the administration of CD’s are not responsible or accountable for knowing the therapeutic uses, doses and side effects of the drugs administered to patients.
The RN is the accountable member of staff when a HCSW is required to act as a witness for the administration of controlled drugs.
* If a calculation is necessary i.e.: syringe driver/infusion and there are no other registered staff on shift to check the calculation then the nurse must document in the CD register/Omnicell notes ‘No RN on duty to check the calculation.’
If the RN is unsure of the calculation and requires a second check, then they can contact Borders Urgent Care Centre (BUCC) on 01896 Crisis Team Charge Nurse or the on-call Pharmacist via NHS Borders switchboard 01896 826000.
BUCC staff and the on call pharmacists must be able to see the Kardex or paperwork for syringe driver checks, they will need to be scanned/e-mailed to the appropriate clinician for review.
The preparation of syringe drivers should be planned so they are made up when there are two RNs available. This may involve them being prepared in advance of the shift ending to prevent and reduce the requirement for syringe drivers to be changed overnight. ensuring that there are 2 RN’s available for the entire process.
*Calculation i.e.: where part of a vial is required to make up a dose a calculation would be necessary. (when 2 x 20mg tablets are required to make 40mg dose this is not considered to be a calculation).
These guidelines apply to the following schedule 2 controlled drugs (commonly used in red)
Alfentanil injection (various strengths)spray
Codeine injection 60mg/ml
Cocaine (eye drops & solution)
Dexamfetamine tablets
Diamorphine injection (various strengths)
Fentanyl Patches/S/L tablets/injection (various strengths)/lozenges/nasal spray
Hydromorphone injection
Ketamine injection/oral solution Levobupivacaine 0.1% Fentanyl infusion
Lisdamfetamine caps
Meprobamate tabs
Methadone mixture/injection/tabs
Methylphenidate tablets (various brands)
Morphine sulphate caps/tabs/injection/solution 20mg/ml
Oxycodone tab/caps/injection/liquid
Pethidine tabs
Remifentanil
Tapentadol tabs
Targinact tabs
Schedule 3 controlled drugs that are treated as schedule 2 (i.e. recorded in register)
Buprenorphine tabs/Patches
Please note that the controlled drugs marked in red are commonly used so may be kept as stock on various BGH wards.
When infusions/syringe drivers are required to be made up involving any of the above drugs the HCSW must only be asked to verify that the correct drug has been selected and that the remaining balance in the CD cabinet/Omnicell matches that of the CD register/Omnicell cabinet. As stated above the HCSW cannot be asked to confirm any calculations to achieve a dose.